Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP

Delayed Quote. Delayed  - 06/30 03:42:57 pm
10.83 USD   -0.18%
05/31 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at ..
05/18 SUCAMPO PHARMAC : Announces Webcast of Its Presentation at the 2016 ..
05/17 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at ..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/24/2016 06/27/2016 06/28/2016 06/29/2016 06/30/2016 Date
10.71(c) 10.45(c) 10.92(c) 10.85(c) 10.83 Last
651 344 458 104 483 680 539 403 12 390 Volume
-2.19% -2.43% +4.50% -0.64% -0.18% Change
More quotes
Financials ($)
Sales 2016 204 M
EBIT 2016 83,7 M
Net income 2016 31,6 M
Debt 2016 141 M
Yield 2016 -
Sales 2017 227 M
EBIT 2017 106 M
Net income 2017 63,4 M
Debt 2017 87,4 M
Yield 2017 -
P/E ratio 2016 14,86
P/E ratio 2017 7,61
EV / Sales2016 3,13x
EV / Sales2017 2,57x
Capitalization 497 M
More Financials
Company
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company which engages in research, discovery, development and commercialization of proprietary drugs in the Americas, Europe and Asia.It is developing prostones, which are ion channel activators, to treat gastrointestinal, ophthalmic and... 
More about the company
Surperformance© ratings of Sucampo Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on SUCAMPO PHARMACEUTICALS, I
06/28 SUCAMPO PHARMACEUTICALS : Completion of Acquisition or Disposition of Assets, Fi..
06/08 SUCAMPO PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Hold..
05/31 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferie..
05/18 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the 2016 UBS ..
05/17 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2016 UBS..
05/12 VEEVA SYSTEMS : Sucampo Standardizes on Veeva Vault for a Single Source of Truth..
05/05 SUCAMPO PHARMACEUTICALS : Management's Discussion and Analysis of Financial Cond..
05/04 SUCAMPO PHARMACEUTICALS : reports 1Q loss
05/04 SUCAMPO PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, R..
05/04 Sucampo Reports Strong Results for First Quarter of 2016
More news
Sector news : Bio Therapeutic Drugs
06/28DJGILEAD SCIENCES : Gets FDA Approval for Combo Hepatitis C Drug
06/28DJGILEAD SCIENCES : Gets FDA Approval for Combo Hepatitis C Drug
06/28DJGILEAD SCIENCES : Gets FDA Approval for Combo Hepatitis C Drug
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
More sector news : Bio Therapeutic Drugs
4-Traders Strategies on SUCAMPO PHARMACEUTICALS, I 
2015The bullish trend is not over
More Strategies
News from SeekingAlpha
05/28 LANNETT : Structural Benefits Of The Kremers Acquisition: 100+% Upside
05/04 Sucampo Pharmaceuticals' (SCMP) CEO Peter Greenleaf on Q1 2016 Results - Earn..
05/04 Sucampo beats by $0.02, beats on revenue
05/03 Notable earnings before Wednesday?s open
04/26 HEDGED RELYPSA LONGS : Consider This Course Correction
Advertisement
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Full-screen chart
Technical analysis trends SUCAMPO PHARMACEU...
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions